Comparison of fetal growth by maternal prenatal acetaminophen use

Pediatr Res. 2019 Aug;86(2):261-268. doi: 10.1038/s41390-019-0379-7. Epub 2019 Mar 25.

Abstract

Background: Equivocal findings exist regarding prenatal acetaminophen use and various adverse neonatal and childhood health outcomes, though with no data on fetal growth. We evaluated whether fetal growth differed by maternal acetaminophen use.

Methods: Racially diverse, healthy women with low-risk antenatal profiles from 12 US clinical centers were enrolled in a prospective cohort study and followed until delivery. Ultrasound measurements of fetal parameters and self-reported prenatal acetaminophen use were collected at enrollment and up to five follow-up visits. Prenatal acetaminophen use was dichotomized as none or any.

Results: Among 2291 women, 932 (41%) reported the use of acetaminophen medications during the current pregnancy. Estimated growth curves of fetal parameters did not differ between women reporting use of any medication containing acetaminophen and women with no reported use of the same.

Conclusion: Among healthy mothers with low-risk pregnancies, maternal acetaminophen use was not associated with alterations in fetal growth.

Trial registration: ClinicalTrials.gov NCT00912132.

Publication types

  • Comparative Study
  • Multicenter Study
  • Research Support, N.I.H., Intramural

MeSH terms

  • Acetaminophen / adverse effects*
  • Adult
  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
  • Biometry
  • Body Mass Index
  • Female
  • Fetal Development / drug effects*
  • Gestational Age
  • Humans
  • Infant, Newborn
  • Maternal Age
  • Maternal Exposure*
  • Mothers
  • Pregnancy
  • Pregnancy Complications
  • Prospective Studies
  • Risk
  • Risk Factors
  • Self Report
  • Treatment Outcome
  • Ultrasonography
  • Ultrasonography, Prenatal
  • Young Adult

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Acetaminophen

Associated data

  • ClinicalTrials.gov/NCT00912132